Short Answer
Complete Explanation
A significant bronchodilator response refers to a measurable improvement in lung function after the administration of a short‑acting bronchodilator during pulmonary function testing, most commonly spirometry. The response is quantified by the change in forced expiratory volume in one second (FEV1) or forced vital capacity (FVC) and is used to assess airway reversibility, aid diagnosis, and evaluate treatment efficacy.
- Definition:
An increase in FEV1 or FVC of at least 12% and 200 mL from the pre‑bronchodilator value is generally accepted as a significant response. - Clinical significance:
Indicates reversible airway obstruction, supporting a diagnosis of asthma or a component of asthma‑COPD overlap. - Typical thresholds:
Guidelines (e.g., ATS/ERS) recommend the 12%/200 mL criterion; some studies also use a 15% change for stricter specificity. - Conditions where it is observed:
Asthma, asthma‑COPD overlap, occasional reversible obstruction in early COPD, and sometimes in occupational lung diseases. - Interpretation in practice:
A positive response guides clinicians to consider inhaled corticosteroids and may influence the choice of long‑acting bronchodilators.
Common Misconceptions
A significant bronchodilator response rules out COPD.
While COPD is typically less reversible, a subset of patients can show a positive response, especially early in disease.
Any improvement after bronchodilator use is clinically important.
Small changes (<12% or <200 mL) may be within measurement variability and are not considered significant.
FAQ
What constitutes a significant bronchodilator response?
A rise of at least 12% and 200 mL in FEV1 or FVC after inhaling a short‑acting bronchodilator, measured during spirometry, is considered significant.
Why is bronchodilator responsiveness important in asthma diagnosis?
Asthma is characterized by reversible airway obstruction. Demonstrating a significant bronchodilator response confirms reversibility, supporting an asthma diagnosis and influencing treatment choices.
Can patients with COPD show a significant bronchodilator response?
Yes, especially in early disease or in asthma‑COPD overlap. However, the magnitude of response is generally smaller than in asthma, and clinicians interpret results in the context of clinical history and imaging.
Leave a Reply